A study evaluating the Pharmacokinetics & Pharmacodynamics of Selatogrel following single-dose subcutaneous administration in stable Coronary-artery-disease (CAD) patients
Latest Information Update: 03 Jan 2020
At a glance
- Drugs Selatogrel (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics; Pharmacokinetics
Most Recent Events
- 03 Jan 2020 New trial record